Senior insider sale
CLO & Secretary at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$5.45M
20K shares
What this filing means
REARDON ANDREW plans to sell 20K shares of LIGAND PHARMACEUTICALS INC valued at approximately $5.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006760
Officer· CLO & Secretary
Since Mar 2026
20K
Shares to sell
$5.45M
Approx. market value
10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/1/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Exercise of Stock Options Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5K
Market value
$1.14M
6/1/2026
—Completed
Units to sell
5K
Market value
$1.16M
5/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$3.16M
7/1/2026
Total
Units
20K
Value
$5.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 5K | $1.14M | — | Completed |
5/1/2026 | 5K | $1.16M | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 10K | $3.16M | NASDAQ | Planned |
| Total | 20K | $5.45M | ||